查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572953

性傳染病檢查市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2031年

Sexually Transmitted Disease Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 179 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球性傳染病 (STD) 檢測市場的綜合報告，深入分析了關鍵市場動態，包括市場推動因素、趨勢、機會和挑戰。該報告提供了有關當前市場結構和未來成長前景的寶貴見解，以幫助利害關係人做出明智的決策。

主要的洞察

  • 性傳染病檢測市場規模（2024 年）：100.3 億美元
  • 預測市場規模（2031 年）：170.8 億美元
  • 全球市場成長率（2024-2031 年複合年增長率）：7.9%

性病檢測市場：調查範圍

STD 檢測市場包括 HIV、梅毒、淋病、披衣菌和人類乳突病毒 (HPV) 等性傳染病的診斷檢測。性傳染感染盛行率的增加、公眾健康意識的提高以及獲得醫療保健服務的機會的改善是推動性傳染感染檢測需求的關鍵因素。該市場還包括各種測試方法，例如基於實驗室的測試、現場護理測試和快速診斷。自檢套件的接受度不斷提高以及診斷工具的技術進步進一步推動了市場的成長。

推動市場成長的因素：

有幾個因素正在推動全球性病檢測市場的成長。人們對性健康的認識不斷提高，政府加大了預防性傳染病的力度，以及性傳染病發生率的上升是關鍵因素。此外，不斷擴大的醫療基礎設施、先進診斷工具的可用性以及對性傳染病早期檢測和治療的需求不斷增加也在推動市場成長。此外，融合遠距醫療和數位健康平台的檢測和諮詢服務正在進一步加速市場推廣。

市場阻礙因素：

儘管性病檢測市場有著積極的成長前景，但它仍面臨著一些挑戰。在某些地區，社會恥辱和對性傳染病缺乏認識阻礙了廣泛的檢測。資金不足的環境也面臨著檢測服務的有限性以及與某些診斷方法相關的高成本的挑戰。區域監管差異和對專業醫療基礎設施的需求也可能限制某些地區的市場成長。

市場機會：

由於診斷技術的進步和對自我檢測試劑盒的需求增加，性傳染病檢測市場提供了巨大的成長機會。快速現場診斷測試和家庭測試解決方案的發展正在為市場擴張開闢新途徑。醫療保健提供者、診斷公司和公共衛生組織之間的合作可以進一步增強檢測範圍和可近性。此外，增加對性健康意識活動和研究措施的投資，以遏制性傳染病的傳播，正在為該市場的公司創造新的成長機會。

本報告解決的關鍵問題

  • 推動性病檢測市場全球成長的關鍵因素是什麼？
  • 哪些地區和市場領域對性病檢測服務的需求最高？
  • 診斷技術的進步如何影響性傳染病檢測市場的競爭格局？
  • 誰是性傳染病檢測市場的主要參與者？ 他們採取了哪些策略來維持自己的市場地位？
  • 全球性病檢測市場的新趨勢與未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
    • 主要的趨勢
  • 宏觀經濟要素
    • 全球GDP成長展望
    • 全球醫療保健費支出展望
  • COVID-19影響分析
  • 預測要素 - 相關性及影響

第3章 附加價值的洞察

  • 產品採用分析
  • 疾病流行病學
  • 法規情形
  • 價值鏈分析
  • 主要的交易與合併
  • 大環境分析
  • 波特的五力分析

第4章 全球性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

  • 全球性傳染病檢查市場展望:產品
    • 簡介/主要調查結果
    • 過去的市場規模(一百萬美元)分析，各產品，2019年～2023年
    • 目前市場規模(一百萬美元)分析與預測，各產品，2024年～2031年
      • 設備·服務
      • 消耗品
      • 軟體
  • 市場魅力分析:產品
  • 全球性傳染病檢查市場展望:用途
    • 簡介/主要調查結果
    • 過去的市場規模(一百萬美元)分析，各用途，2019年～2023年
    • 目前市場規模(一百萬美元)分析與預測，各用途，2024年～2031年
      • CT/NG檢驗
      • 梅毒檢驗
      • HSV檢驗
  • 市場魅力分析:用途
  • 全球性傳染病檢查市場展望:技術
    • 簡介/主要調查結果
    • 過去的市場規模(一百萬美元)分析，各技術，2019年～2023年
    • 目前市場規模(一百萬美元)分析與預測，各技術，2024年～2031年
      • 免疫檢測
      • 分子診斷
  • 市場魅力分析:技術

第5章 全球性傳染病檢查市場展望:地區

  • 主要的亮點
  • 過去的市場規模(一百萬美元)分析，各地區，2019年～2023年
  • 目前市場規模(一百萬美元)分析與預測，各地區，2024年～2031年
    • 北美
    • 歐洲
    • 東亞
    • 南亞·大洋洲
    • 南美
    • 中東·非洲
  • 市場魅力分析:地區

第6章 北美的性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

第7章 歐洲的性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

第8章 東亞的性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

第9章 南亞·大洋洲的性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

第10章 南美的性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

第11章 中東·非洲的性傳染病檢查市場展望:實際成果(2019年～2023年)與預測(2024年～2031年)

第12章 競爭情形

  • 市場佔有率分析，2024年
  • 市場結構
    • 競爭激烈化地圖:各市場
    • 競爭儀表板
  • 企業簡介(詳細內容 - 概要，財務，策略，最近的趨勢)
    • BD
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • Abbott
    • Cepheid(Danaher)
    • Qiagen
    • OraSure Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Thermo Fisher Scientific, Inc.
    • Seegene Inc.
    • DiaSorin SPA
    • 其他

第13章 附錄

  • 調查手法
  • 調查的前提條件
  • 縮寫和簡稱
簡介目錄
Product Code: PMRREP34842

Persistence Market Research has recently released a comprehensive report on the global Sexually Transmitted Disease (STD) Testing Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This report offers valuable insights into the current market structure and future growth prospects, aiding stakeholders in making informed decisions.

Key Insights:

  • STD Testing Market Size (2024E): US$10.03 Bn
  • Projected Market Value (2031F): US$17.08 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.9%

STD Testing Market - Report Scope:

The STD Testing market includes diagnostic tests for sexually transmitted infections such as HIV, syphilis, gonorrhea, chlamydia, and human papillomavirus (HPV). The growing prevalence of STDs, increased public health awareness, and improved access to healthcare services are key factors driving the demand for STD testing. This market also includes various testing methods such as laboratory-based testing, point-of-care testing, and rapid diagnostics. The increasing acceptance of self-testing kits and technological advancements in diagnostic tools further support market growth.

Market Growth Drivers:

Several factors are driving the growth of the global STD Testing market. Rising awareness about sexual health, increased government initiatives for STD prevention, and growing incidences of sexually transmitted infections are key contributors. The expansion of healthcare infrastructure, the availability of advanced diagnostic tools, and increasing demand for early detection and treatment of STDs also propel market growth. Additionally, the integration of telemedicine and digital health platforms for testing and consultation services is further accelerating market adoption.

Market Restraints:

Despite the positive growth outlook, the STD Testing market faces several challenges. Social stigma and lack of awareness about STDs in certain regions hinder testing adoption. In low-resource settings, limited access to testing services and high costs associated with some diagnostic procedures also pose challenges. The variation in regulations across regions and the need for specialized healthcare infrastructure may also restrict market growth in some areas.

Market Opportunities:

The STD Testing market offers significant opportunities for growth, driven by advancements in diagnostic technologies and increasing demand for self-testing kits. The development of rapid point-of-care diagnostic tests and home-based testing solutions are opening new avenues for market expansion. Collaborations between healthcare providers, diagnostic companies, and public health organizations can further enhance testing outreach and accessibility. Additionally, rising investments in sexual health awareness campaigns and research initiatives to combat the spread of STDs present new growth opportunities for companies in this market.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the STD Testing market?
  • Which regions and market segments are experiencing the highest demand for STD testing services?
  • How are technological advancements in diagnostics impacting the competitive landscape of the STD Testing market?
  • Who are the major players in the STD Testing market, and what strategies are they employing to maintain their market positions?
  • What are the emerging trends and future outlooks for the global STD Testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global STD Testing market, including Abbott Laboratories, F. Hoffmann-La Roche Ltd, and bioMerieux SA, are focusing on technological innovation, expanding their product portfolios, and forming strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic tools, such as rapid tests and molecular diagnostics, to meet the growing demand for accurate and timely STD testing. Collaborations with healthcare providers, public health organizations, and government bodies are essential for increasing testing accessibility and promoting early detection initiatives.

Key Companies Profiled:

  • BD
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc.
  • Abbott
  • Cepheid (Danaher)
  • Qiagen
  • OraSure Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Thermo Fisher Scientific, Inc.
  • Seegene Inc.
  • DiaSorin S.P.A

STD Testing Industry Research by Category:

By Product

  • Instruments & Services
  • Consumables
  • Software

By Application

  • CT/NG Testing
  • Syphilis Testing
  • HSV Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Sexually Transmitted Disease Testing Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Global Sexually Transmitted Disease Testing Market Outlook: Product
    • 4.1.1. Introduction / Key Findings
    • 4.1.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
    • 4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
      • 4.1.3.1. Instruments & Services
      • 4.1.3.2. Consumables
      • 4.1.3.3. Software
  • 4.2. Market Attractiveness Analysis: Product
  • 4.3. Global Sexually Transmitted Disease Testing Market Outlook: Application
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
      • 4.3.3.1. CT/NG Testing
      • 4.3.3.2. Syphilis Testing
      • 4.3.3.3. HSV Testing
  • 4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Sexually Transmitted Disease Testing Market Outlook: Technology
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2023
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
      • 4.5.3.1. Immunoassay
      • 4.5.3.2. Molecular Diagnostics
  • 4.6. Market Attractiveness Analysis: Technology

5. Global Sexually Transmitted Disease Testing Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Application
    • 6.3.4. By Technology
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 6.5.1. Instruments & Services
    • 6.5.2. Consumables
    • 6.5.3. Software
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 6.6.1. CT/NG Testing
    • 6.6.2. Syphilis Testing
    • 6.6.3. HSV Testing
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 6.7.1. Immunoassay
    • 6.7.2. Molecular Diagnostics
  • 6.8. Market Attractiveness Analysis

7. Europe Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Application
    • 7.3.4. By Technology
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkiye
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 7.5.1. Instruments & Services
    • 7.5.2. Consumables
    • 7.5.3. Software
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 7.6.1. CT/NG Testing
    • 7.6.2. Syphilis Testing
    • 7.6.3. HSV Testing
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 7.7.1. Immunoassay
    • 7.7.2. Molecular Diagnostics
  • 7.8. Market Attractiveness Analysis

8. East Asia Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By Technology
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 8.5.1. Instruments & Services
    • 8.5.2. Consumables
    • 8.5.3. Software
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 8.6.1. CT/NG Testing
    • 8.6.2. Syphilis Testing
    • 8.6.3. HSV Testing
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 8.7.1. Immunoassay
    • 8.7.2. Molecular Diagnostics
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Application
    • 9.3.4. By Technology
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 9.5.1. Instruments & Services
    • 9.5.2. Consumables
    • 9.5.3. Software
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 9.6.1. CT/NG Testing
    • 9.6.2. Syphilis Testing
    • 9.6.3. HSV Testing
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 9.7.1. Immunoassay
    • 9.7.2. Molecular Diagnostics
  • 9.8. Market Attractiveness Analysis

10. Latin America Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By Technology
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 10.5.1. Instruments & Services
    • 10.5.2. Consumables
    • 10.5.3. Software
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.6.1. CT/NG Testing
    • 10.6.2. Syphilis Testing
    • 10.6.3. HSV Testing
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 10.7.1. Immunoassay
    • 10.7.2. Molecular Diagnostics
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By Technology
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 11.4.1. GCC Countries
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 11.5.1. Instruments & Services
    • 11.5.2. Consumables
    • 11.5.3. Software
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 11.6.1. CT/NG Testing
    • 11.6.2. Syphilis Testing
    • 11.6.3. HSV Testing
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 11.7.1. Immunoassay
    • 11.7.2. Molecular Diagnostics
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. BD
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. F. Hoffmann-La Roche Ltd
    • 12.3.3. Hologic Inc.
    • 12.3.4. Abbott
    • 12.3.5. Cepheid (Danaher)
    • 12.3.6. Qiagen
    • 12.3.7. OraSure Technologies, Inc.
    • 12.3.8. Bio-Rad Laboratories, Inc.
    • 12.3.9. bioMerieux SA
    • 12.3.10. Thermo Fisher Scientific, Inc.
    • 12.3.11. Seegene Inc.
    • 12.3.12. DiaSorin S.P.A
    • 12.3.13. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations